<div id="readability-page-1"><div><p>As the Asian markets navigate a landscape marked by mixed performances in key indices, investors are increasingly looking toward niche opportunities for potential growth. Penny stocks, often associated with smaller or newer companies, continue to capture attention due to their potential for significant returns when backed by solid financials. Despite being an outdated term, these stocks provide a unique opportunity for discovering hidden value in quality companies that might be overlooked by larger market players.</p><h3>Top 10 Penny Stocks In Asia</h3><table><tbody><tr><td><strong>Name</strong></td><td><strong>Share Price</strong></td><td><strong>Market Cap</strong></td><td><strong>Rewards &amp; Risks</strong></td></tr><tr><td>Lever Style (SEHK:1346)</td><td>HK$1.45</td><td>HK$896.85M</td><td>✅ 4 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td><td>THB2.50</td><td>THB1.05B</td><td>✅ 3 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>TK Group (Holdings) (SEHK:2283)</td><td>HK$2.55</td><td>HK$2.12B</td><td>✅ 4 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td><td>SGD0.108</td><td>SGD56.54M</td><td>✅ 2 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td><td>SGD3.56</td><td>SGD14.01B</td><td>✅ 5 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Anton Oilfield Services Group (SEHK:3337)</td><td>HK$0.79</td><td>HK$2.1B</td><td>✅ 3 ⚠️ 2 View Analysis &gt;</td></tr><tr><td>NagaCorp (SEHK:3918)</td><td>HK$4.81</td><td>HK$21.27B</td><td>✅ 5 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Livestock Improvement (NZSE:LIC)</td><td>NZ$1.00</td><td>NZ$137.01M</td><td>✅ 2 ⚠️ 5 View Analysis &gt;</td></tr><tr><td>Bosideng International Holdings (SEHK:3998)</td><td>HK$4.40</td><td>HK$51.08B</td><td>✅ 4 ⚠️ 2 View Analysis &gt;</td></tr><tr><td>Scott Technology (NZSE:SCT)</td><td>NZ$2.88</td><td>NZ$237.99M</td><td>✅ 4 ⚠️ 1 View Analysis &gt;</td></tr></tbody></table><p>Click here to see the full list of 954 stocks from our  Asian Penny Stocks screener.</p><p>Let's uncover some gems from our specialized screener.</p><h2>Nickel Asia (PSE:NIKL)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Nickel Asia Corporation operates in the Philippines, focusing on the mining and exploration of nickel saprolite, limonite ore, limestone, and quarry materials with a market capitalization of ₱61.58 billion.</p><p><strong>Operations:</strong> The company's revenue is primarily derived from its mining operations, with significant contributions from Mining - TMC (₱10.81 billion), Mining - RTN (₱7.87 billion), Mining - HMC (₱3.11 billion), and Mining - CMC (₱3.49 billion); additional income comes from power generation through Power - EPI (₱1.03 billion) and Power - NAC (₱212.40 million), as well as services provided by RTN/TMC/CDTN amounting to ₱1.03 billion.</p><p><strong>Market Cap:</strong> ₱61.58B</p><p>Nickel Asia Corporation, with a market cap of ₱61.58 billion, has shown robust financial performance recently, reporting significant revenue and net income growth compared to the previous year. The company declared special dividends payable in December 2025, indicating strong cash flow management. Despite its debt increasing over five years, it remains well-covered by operating cash flow and is supported by substantial short-term assets exceeding liabilities. However, its earnings growth doesn't match the broader industry trends and forecasts suggest a potential decline in future earnings. Management changes are underway to potentially enhance strategic direction and governance stability.</p><ul><li>Take a closer look at Nickel Asia's potential here in our financial health report.</li><li>Review our growth performance report to gain insights into Nickel Asia's future.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis"/><figcaption>PSE:NIKL Debt to Equity History and Analysis as at Jan 2026</figcaption></figure><h2>Jinhai Medical Technology (SEHK:2225)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Jinhai Medical Technology Limited is an investment holding company that offers minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore, with a market cap of HK$7.25 billion.</p><p><strong>Operations:</strong> The company's revenue is derived from two primary regions: Singapore, contributing SGD 14.82 million, and the People's Republic of China, accounting for SGD 19.83 million.</p><p><strong>Market Cap:</strong> HK$7.25B</p><p>Jinhai Medical Technology faces financial challenges despite its HK$7.25 billion market cap, as it remains unprofitable with losses increasing by 83.8% annually over five years. The company has short-term assets of SGD 23.7 million exceeding both its short and long-term liabilities, indicating a solid liquidity position. Although it recently raised capital to extend its cash runway beyond the initial three months forecast, the net debt to equity ratio is satisfactory at 16.5%. Management and board members bring experience with average tenures of 4.3 and 6.5 years respectively, providing stability amid ongoing financial hurdles.</p><ul><li>Navigate through the intricacies of Jinhai Medical Technology with our comprehensive balance sheet health report here.</li><li>Understand Jinhai Medical Technology's track record by examining our performance history report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis"/><figcaption>SEHK:2225 Financial Position Analysis as at Jan 2026</figcaption></figure><h2>Yangzijiang Financial Holding (SGX:YF8)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> Yangzijiang Financial Holding Ltd. is an investment holding company involved in investment-related activities in China and Singapore, with a market cap of SGD1.41 billion.</p><p><strong>Operations:</strong> The company generates revenue of SGD288.47 million from its investment business segment.</p><p><strong>Market Cap:</strong> SGD1.41B</p><p>Yangzijiang Financial Holding Ltd., with a market cap of SGD1.41 billion, shows strong financial health as its short-term assets of SGD2.2 billion surpass both short and long-term liabilities significantly, and it operates debt-free. Despite earnings growth of 128.4% over the past year, future earnings are expected to decline by an average of 5.7% annually over the next three years. The company's stock trades at a significant discount to estimated fair value, but high volatility persists in its share price recently. Recent executive changes include new appointments in key positions following a strategic spin-off decision, suggesting potential shifts in company direction.</p><ul><li>Click here and access our complete financial health analysis report to understand the dynamics of Yangzijiang Financial Holding.</li><li>Learn about Yangzijiang Financial Holding's future growth trajectory here.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis"/><figcaption>SGX:YF8 Debt to Equity History and Analysis as at Jan 2026</figcaption></figure><h2>Where To Now?</h2><ul><li>Unlock our comprehensive list of 954  Asian Penny Stocks by clicking here.</li><li>Ready For A Different Approach? Trump has pledged to &#34;unleash&#34; American oil and gas and these 22 US stocks have developments that are poised to benefit.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p></div></div>

01346

<p>As Asian markets show mixed performances, investors are focusing on penny stocks for potential growth. These stocks, linked to smaller companies, offer opportunities for significant returns. Notable mentions include Lever Style, Asia Medical and Agricultural Laboratory, and Nickel Asia Corporation, which has shown strong financial performance despite increasing debt. Jinhai Medical Technology faces profitability challenges, while Yangzijiang Financial Holding demonstrates strong financial health but anticipates future earnings decline. Overall, the penny stock landscape in Asia presents both risks and rewards for investors looking for hidden value.</p>

Asian Market Highlights: Penny Stocks To Watch In January 2026